Wolverine Trading
REGN icon

Wolverine Trading’s Regeneron Pharmaceuticals REGN Stock Holding History

Wolverine Trading’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.9M Buy
30,161
+10,583
+54% +$5.98M 0.01% 664
2025
Q2 		$10.2M Buy
19,578
+4,588
+31% +$2.56M 0.01% 702
2025
Q1 		$9.55M Buy
14,990
+1,802
+14% +$1.24M 0.01% 660
2024
Q4 		$9.27M Buy
13,188
+11,552
+706% +$9.69M 0.01% 827
2024
Q3 		$1.71M Buy
1,636
+1,012
+162% +$1.13M ﹤0.01% 1843
2024
Q2 		$656K Sell
624
-4,513
-88% -$4.37M ﹤0.01% 2580
2024
Q1 		$4.94M Buy
5,137
+2,685
+110% +$2.55M 0.01% 1032
2023
Q4 		$2.15M Sell
2,452
-2,083
-46% -$1.72M ﹤0.01% 1665
2023
Q3 		$3.73M Buy
+4,535
New +$3.56M ﹤0.01% 1170
2023
Q1 		– Sell
-55,200
Closed -$39.8M – 4814
2022
Q4 		$39.8M Buy
55,200
+54,753
+12,249% +$40.4M 0.06% 238
2022
Q3 		$309K Buy
+447
New +$281K ﹤0.01% 3123
2022
Q2 		– Sell
-3,898
Closed -$2.53M – 5510
2022
Q1 		$2.7M Sell
3,898
-1,083
-22% -$685K ﹤0.01% 1500
2021
Q4 		$3.2M Sell
4,981
-4,370
-47% -$2.69M ﹤0.01% 1470
2021
Q3 		$5.67M Buy
9,351
+5,121
+121% +$3.18M 0.01% 1205
2021
Q2 		$2.31M Sell
4,230
-7,342
-63% -$3.72M ﹤0.01% 1841
2021
Q1 		$5.45M Buy
11,572
+10,776
+1,354% +$5.25M 0.01% 1053
2020
Q4 		$381K Buy
+796
New +$430K ﹤0.01% 3476
2020
Q1 		– Sell
-5,833
Closed -$2.18M – 5146
2019
Q4 		$2.18M Buy
5,833
+2,173
+59% +$731K 0.01% 1763
2019
Q3 		$1M Buy
+3,660
New +$1.08M ﹤0.01% 1979
2019
Q1 		– Sell
-3,482
Closed -$1.26M – 5159
2018
Q4 		$1.26M Buy
3,482
+2,336
+204% +$855K ﹤0.01% 1781
2018
Q3 		$463K Buy
+1,146
New +$436K ﹤0.01% 3200
2018
Q1 		– Sell
-4,049
Closed -$1.41M – 5709
2017
Q4 		$1.52M Sell
4,049
-2,464
-38% -$998K 0.01% 1766
2017
Q3 		$2.91M Buy
+6,513
New +$3.1M 0.01% 1096
2017
Q1 		– Sell
-852
Closed -$316K – 4866
2016
Q4 		$313K Buy
+852
New +$324K ﹤0.01% 3219

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wolverine Trading's REGN Position: Q3 2025 in Review

Wolverine Trading increased its Regeneron Pharmaceuticals (REGN) stake by 54% in Q3 2025, buying an estimated $5.98M and bringing the position to 30,161 shares worth $16.9M. The position accounts for 0.01% of the portfolio, ranked #664.

Wolverine Trading first reported a position in REGN in Q4 2016 and has held it in 24 quarters since. The position peaked at $39.8M in Q4 2022. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Wolverine Trading held 30,161 shares of Regeneron Pharmaceuticals worth $16.9M as of Q3 2025.
  • Wolverine Trading bought 10,583 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $5.98M.
  • Regeneron Pharmaceuticals made up 0.01% of Wolverine Trading's portfolio in Q3 2025, its #664 holding.
  • Wolverine Trading first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 24 quarters since.
  • Wolverine Trading's Regeneron Pharmaceuticals position peaked at $39.8M in Q4 2022.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.